AC
AGN

Aaron Cowen’s Allergan plc AGN Stock Holding History

Aaron Cowen’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-466,300
Closed -$107M – 63
2016
Q3 		$107M Buy
+466,300
New +$114M 3.45% 9
2016
Q2 		– Sell
-464,274
Closed -$124M – 37
2016
Q1 		$124M Sell
464,274
-270,767
-37% -$77.5M 4.71% 10
2015
Q4 		$230M Buy
735,041
+162,000
+28% +$48.2M 11.31% 1
2015
Q3 		$156M Buy
573,041
+92,800
+19% +$28.5M 16.51% 1
2015
Q2 		$146M Buy
480,241
+87,500
+22% +$26.1M 6.89% 1
2015
Q1 		$117M Buy
392,741
+1,740
+0.4% +$496K 6.97% 1
2014
Q4 		$101M Buy
391,001
+143,501
+58% +$35.9M 7.17% 3
2014
Q3 		$59.7M Sell
247,500
-39,900
-14% -$8.93M 5.22% 5
2014
Q2 		$64.1M Buy
287,400
+32,800
+13% +$6.79M 5.79% 3
2014
Q1 		$52.4M Buy
254,600
+147,200
+137% +$29.2M 6.24% 3
2013
Q4 		$18M Buy
+107,400
New +$16.8M 2.42% 23

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Aaron Cowen's AGN Position: Q4 2016 in Review

Aaron Cowen sold out of Allergan plc (AGN) in Q4 2016, closing a stake of 466,300 shares — an estimated $107M sold.

Aaron Cowen first reported a position in AGN in Q4 2013 and held it in 11 quarters. The position peaked at $230M in Q4 2015. 1,091 funds tracked by Wall St. Rank hold AGN as of Q4 2016.

  • Aaron Cowen reported no remaining Allergan plc position as of Q4 2016 after selling out during the quarter.
  • Aaron Cowen sold 466,300 Allergan plc shares in Q4 2016, an estimated $107M.
  • Aaron Cowen first reported a position in Allergan plc in Q4 2013 and held it in 11 quarters.
  • Aaron Cowen's Allergan plc position peaked at $230M in Q4 2015.
  • 1,091 funds tracked by Wall St. Rank held Allergan plc as of Q4 2016.

Based on Suvretta Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.